BIOGEN INC. 15/45BIOGEN INC. 15/45BIOGEN INC. 15/45

BIOGEN INC. 15/45

No trades
See on Supercharts

US9062XAD5 analysis



Key facts


Issue date
Sep 15, 2015
Maturity date
Sep 15, 2045
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
5.20% (Fixed)
Yield to maturity
5.79%
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.